All Stories

  1. Kidney Transplantation In The Era of Climate Change: Environmental, Structural, and Ethical Implications for Future-Ready Practice
  2. Late-onset lupus nephritis: what is the evidence?
  3. Urinary proteomic profiling to identify early biomarkers of non-diabetic chronic kidney disease
  4. Insights From the UK on Fibromuscular Dysplasia in Pregnancy
  5. Optimization of renin-angiotensin-aldosterone inhibitor therapies for evidence-based indications: A call to action from the cardio-kidney community
  6. Cardiorenal Syndrome in the Elderly: Challenges and Considerations
  7. Gum Hyperplasia in a Patient with Lupus Nephritis
  8. Optimization of Renin-Angiotensin-Aldosterone Inhibitor Therapies for Evidence-Based Indications: a Call to Action From the Cardio-Kidney Community
  9. Anti-nuclear cytoplasmic antibody-associated vasculitis and kidney cancer: A mini review
  10. Noninvasive Assessment of Urinary Exfoliated Proximal Tubule Cell Multispectral Autofluorescence May Differentiate between Causes of Kidney Transplant Dysfunction
  11. Considering the utility of urinary amino acids for early identification of non-diabetic chronic kidney disease
  12. Optimization of renin‐angiotensin‐aldosterone inhibitor therapies for evidence‐based indications: a call to action from the cardio‐kidney community
  13. Does Dialysis Modality Have a Role on Stroke Risk?
  14. Is There a Diagnostic and Prognostic Role for Anti-Nephrin Autoantibodies in Diabetic Nephropathy?
  15. Monkeypox infection in kidney transplant recipients
  16. WCN25-79 NON-INVASIVE DIAGNOSIS OF CHRONIC KIDNEY DISEASE BY MACHINE-LEARNING BASED EVALUATION OF URINARY EXFOLIATED PROXIMAL TUBULE CELL MULTISPECTRAL AUTOFLUORESCENCE
  17. Association Between Glycemic Control and Complications With Concentration of Urinary Exfoliated Proximal Tubule Kidney Cells in People With Diabetes Mellitus
  18. Pericardial cyst: an unexpected diagnosis in a patient presenting with breathlessness
  19. H5N1 Infection and Kidney Pathology: Is There a Link?
  20. Considering kidney replacement therapy initiation based on acute encephalopathy in severe acute kidney injury
  21. Characteristics of Inherited Metabolic Disorders Following Kidney Transplantation: A 13-Year Observational Study
  22. Evaluation of urinary volatile organic compounds as a novel metabolomic biomarker to assess chronic kidney disease progression
  23. Associations between frailty status and humoral response to SARS-cov-2 vaccination in kidney transplantation and dialysis
  24. Gut Microbiota in Patients Receiving Dialysis: A Review
  25. Lessons for the clinical nephrologist: fibromuscular dysplasia in older adults
  26. Infective Endocarditis in Patients Receiving Hemodialysis: A Current Review
  27. Unexpected seronegative response in relapsed PLA2R-associated membranous nephropathy
  28. 499-P: Association between Diabetic Retinopathy and Number of Urinary Exfoliated Proximal Tubule Kidney Cells
  29. Evaluating the Clinical Relevance of Antibodies against Non-Human Leukocyte Antigen in Kidney Transplantation
  30. Autosomal Dominant Polycystic Kidney Disease in Older Adults
  31. #328 Non-invasive assessment of urinary exfoliated proximal tubule cells using multispectral autofluorescence imaging features for early detection of CKD
  32. The Significance of Anti-PLA2R in Diabetic Kidney Disease: Truly a False Positive?
  33. WCN24-213 DIABETIC KIDNEY DISEASE AND NUMBER OF URINARY EXFOLIATED PROXIMAL TUBULE CELLS: IS THERE A LINK?
  34. Incidence, Risk Factors, and Outcomes of De Novo Malignancy following Kidney Transplantation
  35. Using Digital Health Interventions to Promote Prehabilitation Prior to Kidney Transplantation
  36. Clostridioides difficile Infection in Kidney Transplant Recipients
  37. Updates on Renal Replacement Therapy
  38. Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?
  39. Hypertrophic Cardiomyopathy and Chronic Kidney Disease: An Updated Review
  40. Is home dialysis an optimal option during pregnancy?
  41. Frailty and antineutrophil cytoplasmic antibody‐associated vasculitis: What do we know?
  42. Prophylactic ultra-low dose rituximab to maintain remission in relapsing adult minimal change disease
  43. How I Treat Elderly Patients with Kidney Failure with Peritoneal Dialysis
  44. Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes
  45. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  46. Weighing up telehealth for older adults receiving home dialysis
  47. The Role of PLA2R in Primary Membranous Nephropathy: Do We Still Need a Kidney Biopsy?
  48. COVID-19 Infection and Vaccination and Its Relation to Amyloidosis: What Do We Know Currently?
  49. Delivering Personalized, Goal-Directed Care to Older Patients Receiving Peritoneal Dialysis
  50. #4146 LIMITATIONS AND UNCERTAINTIES OF ASSESSING AND MANAGING OLDER PATIENTS WITH ANCA ASSOCIATED VASCULITIS
  51. #5507 ANTIHYPERTENSIVE PRESCRIBING PATTERNS IN CKD: FINDINGS FROM THE SALFORD KIDNEY STUDY
  52. Seizures and chronic kidney disease: An in-depth review
  53. Physiological Associations between Vitamin B Deficiency and Diabetic Kidney Disease
  54. COVID-19 in Elderly Patients Receiving Haemodialysis: A Current Review
  55. Big Data in Chronic Kidney Disease: Evolution or Revolution?
  56. Is It Time to Integrate Frailty Assessment in Onconephrology?
  57. Prescribing Immunosuppressive Treatment for Older People with Glomerular Diseases: Time to Assess Frailty?
  58. Merkel Cell Carcinoma in Kidney Transplant Recipients
  59. Stenotrophomonas maltophilia: A Case Series and Review for an Uncommon Cause of Peritoneal Dialysis-Associated Infection
  60. Impact of frailty status on clinical outcomes in patients receiving peritoneal dialysis
  61. Peritoneal dialysis‐associated peritonitis presenting with Ralstonia pickettii infection: A novel series of three cases during the COVID‐19 pandemic
  62. Improving physical functioning and activity of elderly peritoneal dialysis patients
  63. COVID-19 and hepatorenal syndrome
  64. Home dialysis in older adults: challenges and solutions
  65. Intrinsic Kidney Pathology in Children and Adolescents Following COVID-19 Vaccination: A Systematic Review
  66. Pruritus in Chronic Kidney Disease: An Update
  67. Is HIF-PHI the Answer to Tackle ESA Hyporesponsiveness in the Elderly?
  68. Exfoliated Kidney Cells from Urine for Early Diagnosis and Prognostication of CKD: The Way of the Future?
  69. MO245: Risk Factors for Venous Thrombosis in ANTI-PLA2R + VE AND−VE Primary Membranous Nephropathy: A 6-YEAR Retrospective Analysis
  70. MO480: Predictive Ability of Clinical Assessment Tools For >2 Weeks in-Hospital Stay Following Hip Fracture in Patients Living With CKD: Insights From a 7-Year Prospective Analysis
  71. MO699: Investigating Longer Term Antibody Response Following Covid-19 Vaccination in Patients Receiving Peritoneal Dialysis—a Single-Center Observational Study
  72. Kidney Replacement Therapy in the Intensive Care Unit
  73. Long‐term antibody response following COVID‐19 vaccination in patients receiving peritoneal dialysis
  74. Humoral Response in Hemodialysis Patients Following COVID-19 Vaccination and Breakthrough Infections during Delta and Omicron Variant Predominance
  75. Quality assessment on the delivery of acute kidney replacement therapy in intensive care
  76. Indications and timing of renal replacement therapy initiation in the intensive care unit: An updated review
  77. UNEXPECTED FINDING OF SINGLE BIFID PAPILLARY MUSCLE ANOMALY IN A PATIENT PRESENTING WITH ANGINA PECTORIS
  78. Risk factors of venous thromboembolism in anti-PLA2R-positive and negative primary membranous nephropathy
  79. POS-318 PREDICTIVE ABILITY OF CLINICAL ASSESSMENT TOOLS FOR DELIRIUM FOLLOWING HIP FRACTURE IN PATIENTS LIVING WITH CKD: INSIGHTS FROM A 7-YEAR PROSPECTIVE ANALYSIS
  80. POS-489 RITUXIMAB VERSUS MODIFIED PONTICELLI REGIMEN IN THE MANAGEMENT OF MEMBRANOUS NEPHROPATHY: OUTCOMES FROM A 24-MONTH OBSERVATIONAL ANALYSIS
  81. To What Extent Does Frailty Influence the Risk of Developing Urolithiasis?
  82. Erythropoietin-Stimulating Agent Hyporesponsiveness in Patients Living with Chronic Kidney Disease
  83. Frailty assessment in ANCA-associated vasculitis: current evidence and remaining uncertainties
  84. Concurrent presentation of IgG4-related tubulointerstitial nephritis and ANCA MPO crescentic glomerulonephritis
  85. Vitamin B12 and chronic kidney disease
  86. Intrinsic Kidney Pathology Following COVID-19 Infection in Children and Adolescents: A Systematic Review
  87. Acute interstitial nephritis following SARS-CoV-2 vaccination
  88. An Unusual Cause of AKI in a Kidney Transplant Patient with Merkel Cell Cancer
  89. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review
  90. New-Onset and Relapsed Kidney Histopathology Following COVID-19 Vaccination: A Systematic Review
  91. Etanercept-Induced Anti-Glomerular Basement Membrane Disease
  92. Is home hemodialysis a practical option for older people?
  93. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  94. MO090TRANSPLANT KIDNEY BIOPSY FINDINGS IN COVID-19: A SYSTEMATIC REVIEW
  95. MO1039HEALTH PROFESSIONAL PERSPECTIVES OF FRAILTY STATUS EVALUATION DURING PRE-TRANSPLANT ASSESSMENT
  96. MO533WHICH PARAMETERS BEST PREDICT POSITIVE COVID-19 STATUS FOLLOWING HIP FRACTURE FOR PATIENTS LIVING WITH CKD?
  97. ASPERGILLUS PROSTHETIC VALVE ENDOCARDITIS PRESENTING WITH ACUTE VISUAL LOSS IN AN IMMUNOCOMPETENT PATIENT
  98. POS-348 Predicting difficulties with direct home discharge following hip fracture for patients living with CKD: Insights from a 6-year prospective study
  99. POS-349 WHICH PARAMETERS BEST PREDICT REHOSPITALIZATION FROM A SECOND HIP FRACTURE EVENT FOR PATIENTS LIVING WITH CKD ADMITTED FOLLOWING HIP FRACTURE? A 6-YEAR PROSPECTIVE ANALYSIS
  100. Prognostic performance of clinical assessment tools following hip fracture in patients with chronic kidney disease
  101. Dexamethasone in Hospitalized Patients with Covid-19
  102. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  103. Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
  104. Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
  105. Frailty and the Potential Kidney Transplant Recipient: Time for a More Holistic Assessment?
  106. Primary Ewing Sarcoma of the Lung: A Challenging Case
  107. Patient safety and the role of the Helsinki Declaration on Patient Safety in Anaesthesiology
  108. Effect of delayed secondary care referral on morbidity and mortality in idiopathic pulmonary fibrosis patients treated with antifibrotics
  109. An atypical presentation of subacute cutaneous lupus erythematous
  110. Survival after non-resection of colorectal cancer: the argument for including non-operatives in consultant outcome reporting in the UK
  111. Will endoscopic submucosal dissection (ESD) become the gold standard for laterally spreading tumors (LST)?
  112. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
  113. Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637
  114. Does delay in review of newly-diagnosed idiopathic pulmonary fibrosis (IPF) worsen outcomes?
  115. AB0996 Bone mineral density at different sites as a predictor of rib fractures: a case-control study
  116. Poster Abstracts
  117. Poster Abstracts
  118. PWE-326 Extending the scope of tem – effect of radiotherapy on outcome in locally excised t2 rectal cancer